Prof Phillip Darcy

Related Grants and Projects

• Participant in Adoptive Cell Transfer Incorporating Vaccination (ACTIV) Therapy for Cancer (funded by National Health and Medical Research Council)
• Participant in Combining PI3K, CDK4/6 pathway inhibitors and immunotherapies in triple-negative breast cancer (TNBC): a novel therapy combination (funded by National Health and Medical Research Council)
• Participant in Immunobiology and Immunotherapy of Cancer (funded by National Health and Medical Research Council)
• Principal investigator of New strategies for enhancing chimeric antigen receptor (CAR) T cell therapy for cancer (funded by National Health and Medical Research Council)
• Participant in The role of co-signalling receptors in cytotoxic lymphocyte activity during infection and cancer (funded by National Health and Medical Research Council)